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Introduction
 Over the past few years, cancer has remained a major 
cause of death and the number of individuals affected 
with cancer is continuing to expand (Chaoki et al., 2010). 
Hence, a major portion of the current pharmacological 
research is devoted to anticancer drug design customized 
to fit new molecular targets (Xia et al., 2004). Due to 
enormous propensity of plants, which synthesize a variety 
of structurally diverse bioactive compounds, the plant 
kingdom is a potential source of chemical constituents 
with antitumor and cytotoxic activities (Kim et al., 2005; 
Chin et al., 2006). The rich and diverse plant sources of 
Turkey are likely to provide effective anticancer agents 
(Ozmen et al., 2009; 2010).
 Cyclamen coum is found in the mountains and 
coastal areas that border the southern and eastern Black 
Sea coasts from Bulgaria in the west through Georgia 
and the Crimea in the east. It is also found in the Elburz 
Mountains of northern Iran. It extends from the Hatay in 
southern Turkey, down the eastern Mediterranean coast 
through Syria and the Lebanon into Israel. It grows in 
shady places in coniferous and broadleafed woodland and 
scrub, sometimes growing amongst tree roots and rocks 
(Yesson et al., 2006; Grey-Wilson et al., 2003).
 Although this plant is used for recreational purposes, 
it’s medicinal properties remain unexplored. There is a 
little knowledge on the anti-tumor potential of Cyclamen 
plant (Indop et al., 2006; Altunkeyik et al., 2012). There 
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Abstract
 Cyclamen coum is a traditional medicinal plant in the Turkey. Its anticancer properties and whether cyclamen 
extract induces any cytotoxicity in solid cancer cell lines have not been thoroughly investigated previously. 
Therefore we examined cytotoxic effects on cervical cells; HeLa and non small cell lung cancer cell, H1299, lines; 
Cyclamen extract induced cellular death of both HeLa and H1299 cells in a dose dependent manner. We also 
analyzed the capacity of cyclamen extract to induce apoptosis by the TUNEL method. Here, for the first time 
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can be further analyzed to potentially find novel anticancer compounds. 
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is no data in the literature of the anti-tumor potential of 
compounds of Cyclamen coum. Therefore, the aim of this 
study was to investigate the potential antitumor effects 
of Cyclamen coum on Non Small cell lung cancer lines; 
(NSCLC) H1299 and cervical cancer cell lines; HeLa 
cells.
Materials and Methods
Preparation of the extract 
 Cyclamen specimens were collected in the vicinity of 
Antalya province. Agriculture department was consulted 
to confirm the validity of specimens. The methanol and 
water extracts were prepared as described in the literature, 
in 1 to 2 ratio (weight/weight; 15g plant/60g solvent), 
evaporated to dryness at 65ºC with a rotator evaporator 
and stored at -20ºC, with no exposure to light until use 
(Grey-Wilson et al., 2003). Extracts were diluted with PBS 
(phosphate buffer saline) to obtain different concentrations 
of extracts in order to be used in the experiments.
Cell lines and culture conditions
 HeLa and H1299 cells were cultured in RPMI 1640 
(Sigma aldrich, St. Louis, MO) supplemented with 10% 
fetal bovine serum (Invitrogen, Carlsbad, CA) at 37oC in 
humidified incubator with 5%CO2.
Cell proliferation assay
 The medium was aspirated when cells grown to about 
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90% confluence. Cells were washed with PBS, trypsinized, 
counted with a hemocytometer and seeded into 96-well 
plates (3x104 cell/ml). After 24 h incubation at 37oC 
in a 5%CO2 incubator, the medium was removed and 
cells were treated with plant extracts added in different 
concentrations (0.1, 10, 100, 500, 1000, 2000, 4000 µg/
ml) to the medium of H1299, HeLa cells for 72hrs. Plant 
extract concentrations were prepared in PRMI1640 
medium which included 10% FCS then sterilized with 
passing 0.2 micron filter. At the end of incubation periods, 
medium was removed and cytotoxicity was measured by 
luminometric method using CytotoxGlo kit (Promega). 
And IC50 values were calculated for the plant extract with 
respect to the previously published methodology (Gultekin 
et al., 2006).
Terminal transferase dUTP nick end-labeling apoptosis 
analysis
 HeLa and H1299 cells were trypsinized, counted with 
a hemocytometer, and then seeded into flasks (3×104/
mL). For the detection of the induction of apoptosis of 
cyclamen extract treated, HeLa and H1299 cells were 
treated with IC50 values of each cyclamen extracts for 24 
h at 37°C in a humidified incubator with 5%CO2. At the 
end of the incubation period late apoptotic events were 
analyzed by terminal transferase dUTP nick end-labeling 
(TUNEL) analysis using the In Situ Cell Death Detection 
Kit (Millipore, Billerica, MA, USA). Apoptotic cells were 
counted under the microscope.
Statistical analysis
 All experiments were performed in replicates of 
two and repeated independently to confirm the results. 
Significance of the differences in the means was 
determined using Student’s t test and considering p<0.05 
to be statistically significant.
Results and Discussion
Cancer remains one of the leading causes of death 
around the world. The treatment of cancer may benefit 
from the introduction of novel therapies derived from 
natural products. Natural products have served to provide 
a basis for many of the pharmaceutical agents in current 
use in cancer therapy (Bongiovanni et al., 2006). The 
need to develop more effective and less toxic anticancer 
drugs has prompted researchers to explore new sources 
of pharmacologically active compounds. Natural products 
have long been used to prevent and treat diseases, 
including cancers, and might be good candidates to 
develop anticancer drugs (Kinghorn et al., 1999). Plants 
have substantial potential to discover active anticancer 
compounds as most chemotherapeutic drugs, like taxol and 
vincristin, were already isolated from plants (Pezzuto et 
al., 1997). Therefore, attempts to search of plant-derived 
active compounds for new anticancer treatments might 
be promising.
The present study designed to investigate the potential 
therapeutic abilities of Cyclamen coum extract in cervical 
(HeLa) and lung (H1299) cancer cell lines.
Anticancer properties of Cyclamen coum have not 
been properly studied before. This report is the first to 
show a meaningful cytotoxic effect of the cyclamen 
extract in a solid cancer cell lines. Development of 
novel chemotherapeutics from natural sources is still an 
important concept, because %30 of anticancer agents 
currently available are derived from natural sources 
(Pezzuto et al., 1997).
Isolating novel chemotherapeutics from the cyclamen 
extract may pave the way for a potential new cytotoxic 
that may prove useful in the treatment of various cancers.
Our group is currently working to develop potential 
cytotoxic from the cyclamen extract. Plant derived 
products are excellent sources for the discovery and 
development of new anticancer agents (Abdulaev et al., 
Figure 2. Cyclamen Extract Induces Apoptosis in HeLa 
and H1299 Cells. HeLa and H1299 cells (3×104/mL) were 
incubated with IC50 values of Cyclamen extract for 24 h. After 
the end of the incubation time cells were washed with phosphate-
buffered saline and then assayed by terminal transferase dUTP 
nick end-labeling analysis using an In Situ Cell Death Detection 
Kit (Millipore) system to indicate cellular apoptosis. *p<0.001 
by Student’s t test for cytotoxic effects of plant extract compared 
with the untreated control group
 
Figure 1. Cyclamen Extracts Have Cytotoxic Effects on 
HeLa, H1299 Cell Lines. HeLa, H1299 cells were seeded at a 
density of 3×104/mL in 96-well plates. After 24 h, the cells were 
washed with phosphate-buffered saline, fresh growth medium 
was added, and then cells were treated with Cyclamen extract in 
different concentration for 72 h. At the end of the incubation, cell 
viability was determined in plant extract-treated and untreated 
control groups by the luminometric method. Data are mean±SD 
values (n=3). *p<0.001 by Student’s t test for cytotoxic effects 
of plant extract compared with the untreated control group
 
Table 1. IC50 Values of Cyclamen in Solid Tumor Cell 
Lines
 HeLa H1299
Cyclamen extracts 8,61 µg/ml 9,52 µg/ml
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2001). Drug development programs, especially from 
endemic plant resources still remain to be an important 
means to discover novel cytotoxic agents.
For the detection of specific cytotoxic activity of both 
plant extract luminometric analysis was used as described 
in Materials and Methods. Figure 1 clearly indicates 
that cyclamen extract has cytotoxic effect on both HeLa 
and H1299 cells. According to Figure 1 cytotoxic effect 
of cyclamen extracts on HeLa cell line has stronger 
than H1299 cell line.  We also calculated IC50 values of 
Cyclamen coum in solid tumor cell lines. The cyclamen 
extract was significantly cytotoxic in HeLa (IC50=8.61 
µg/ml) and H1299 cell lines (IC50=9.52 µg/ml) (Table 1). 
Previous reports also shown that Cyclamen coum extract 
can induce cellular cytotoxicity (Arslan et al., 2012) our 
results are good agreement with this previously reports.
To determine whether the induction of cellular death 
by Cyclamen extract was due to the induction of apoptosis, 
a TUNEL assay was used. Figure 2 shows that Cyclamen 
coum extract can induce cellular apoptosis after 24 hours 
treatment. Even though Cyclamen coum extract have the 
ability to induce apoptosis on both HeLa and H1299 cell 
lines, the larger effect on induction of apoptosis was on 
HeLa cell line.
This study, for the first time reports that Cyclamen 
coum extract induces moderate cytotoxicity and apoptosis 
in both cancer cell lines; H1299 and HeLa. The degree 
of cytotoxicity and apoptosis on cervical cancer cell line 
HeLa is more strong than on NSCLC H1299 cell line. 
This selectivity could be due to the sensitivity of the cell 
line to the active compounds in the extract.
These results implied that cyclamen extracts can have 
high potential for the development of chemotherapeutic 
compounds. Obviously, our works show that further work 
needs towards isolating the main cytotoxic compound of 
cyclamen, which may be an encouraging step towards 
development of novel cytotoxics from the extract.
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